Marionette lines (melomental folds)—the vertical creases extending from the corners of the mouth down toward the jawline—require matching the clinical intervention to the underlying anatomical defect. When marionette lines stem primarily from localized dermal volume loss or deep fat pad atrophy, structural hyaluronic acid (HA) dermal fillers (such as Juvéderm Vollure/Volift or Restylane Defyne) directly injected into the fold represent the clinical first-line, typically requiring 1 to 2 syringes and lasting ~12 months. When a hyperactive depressor anguli oris (DAO) muscle actively pulls the oral commissures downward into a persistent downturned expression, micro-dosed DAO neuromodulator ("DAO Botox") softens muscle pull. However, when marionette lines are driven by midface tissue descending over the lower jawline (jowls and skin excess), adding filler alone can create a heavy, overfilled lower face. As the American Society of Plastic Surgeons (ASPS) notes in its procedure reporting, "fillers add volume but do not tighten the skin"—meaning moderate-to-severe lower-face laxity requires PDO threads, energy-based skin tightening, or surgical lifting.
What causes marionette lines (and why the cause dictates the treatment)
Selecting the wrong modality for marionette lines is a primary cause of unsatisfactory aesthetic outcomes and lower-face overfilling.
┌──────────────────────────────────┐
│ Marionette Line Etiology Tree │
└─────────────────┬────────────────┘
│
Three Primary Drivers
┌───────────────────────────┼───────────────────────────┐
│ │ │
1. Volume Loss (Deflation) 2. Muscular Pull (DAO) 3. Tissue Descent (Laxity)
Atrophy of deep melomental Depressor anguli oris Cheek fat pads descend
fat pad & dermal collagen hypertonicity pulls mouth over mandibular border,
creates hollow crease corners downward forming heavy jowl overhang
│ │ │
▼ ▼ ▼
Primary: HA Filler Primary: DAO Botox Primary: Threads / Lift
The complex anatomy of the melomental region
The marionette line forms at a structural junction bounded by distinct facial layers:
- Dermal and subcutaneous fat atrophy: Age-related absorption of the superficial and deep melomental fat pads diminishes structural support beneath the oral commissure.
- Ligamentous anchoring: The mandibular cutaneous ligament firmly anchors skin to the underlying mandible. As surrounding soft tissues deflate and sag, this fixed ligamentous line acts as a tether, deepening the fold.
- Depressor Anguli Oris (DAO) hypertonicity: The DAO muscle originates along the mandible and inserts into the modiolus (the muscular convergence point lateral to the mouth corner). Chronic contraction of the DAO pulls the oral commissure downward into a persistent "sad" expression.
- Gravitational soft tissue descent: Sagging midface fat pads (malar fat) slide downward over the mandibular border, creating a prominent jowl that overhangs the melomental crease.
Dermal filler for marionette lines: HA vs Radiesse vs Sculptra, syringe counts, longevity
Dermal fillers restore structural support in the melomental hollow, lifting the depressed crease flush with surrounding skin.
| Product / Category | Rheological Profile | Longevity & Indication |
|---|---|---|
| Restylane Defyne / Juvéderm Vollure | High G' (stiffness) & moderate flexibility | ~12 months; high dynamic flexibility for the moving mouth |
| Restylane Lyft / Juvéderm Voluma | Very high G' & high lifting capacity | 12–18 months; deep periosteal bolus |
| Radiesse (CaHA) | High G' + long-term calcium biostimulation | 12–18+ months; deep structural expansion |
| Sculptra (PLLA) | Poly-L-lactic acid neocollagenesis | 24+ months; progressive lower-face volumization |
1. Hyaluronic Acid (HA) fillers (Restylane Defyne, Juvéderm Vollure, RHA 3/4)
HA fillers remain the most widely administered option due to immediate results and complete reversibility with hyaluronidase.
- Product selection: The perioral area undergoes constant dynamic motion during speaking, eating, and smiling. Products like Restylane Defyne (XpresHAn Technology) or Juvéderm Vollure (Vycross) provide high G' (elastic modulus) to support the fold while maintaining high flexibility to prevent rigid, unnatural lumps during smiling. For how these HA families differ in formulation and use, see our comparison of Juvéderm vs Restylane.
- Syringe requirements: Mild lines typically require 1.0 mL (1 syringe split between both sides). Moderate to deep creases require 1.5 mL to 2.0 mL total.
- Injection technique: Injectors utilize a 22G or 25G blunt cannula via a single entry point below the oral commissure, placing fanning retrograde linear threads in the deep subcutaneous plane above the periosteum.
2. Calcium Hydroxylapatite (Radiesse)
Radiesse consists of 30% CaHA microspheres suspended in a 70% aqueous carboxymethylcellulose gel carrier.
- Clinical Utility: Radiesse provides immediate volume correction plus long-term collagen and elastin stimulation. It is ideal for deep melomental depressions requiring firm structural lifting, lasting 12 to 18 months. (Note: CaHA is non-reversible with hyaluronidase and must be placed in deep subcutaneous planes).
3. Poly-L-Lactic Acid (Sculptra)
Sculptra functions as a pure biostimulator rather than a traditional space-occupying gel. Over 3 to 6 months, micro-particles of PLLA induce localized sub-dermal neocollagenesis.
- Indication: Sculptra is selected when marionette lines are accompanied by widespread pre-jowl sulcus atrophy and lower-face volume loss. For a detailed biostimulator comparison, read our guide on Sculptra vs Radiesse.
Procedure statistics & ASPS insights
According to the American Society of Plastic Surgeons (ASPS) 2024 Plastic Surgery Statistics Report:
- Hyaluronic acid fillers: 5,331,426 procedures (up 1% from 2023) — the #2 minimally invasive cosmetic procedure in the United States, behind neuromodulator injections (9,883,711, up 4%).
- ASPS Practice Caveat: ASPS explicitly notes that while fillers effectively restore lost volume in hollows, "fillers add volume but do not tighten the skin." Applying excessive filler to treat laxity leads to lower-face heaviness.
DAO Botox: the muscle that pulls your mouth down — does it work and is it safe?
When marionette lines are exacerbated by hyperactive muscular contraction, dermal fillers alone cannot resolve the downward pull. Chemodenervation of the Depressor Anguli Oris (DAO) muscle represents a crucial adjunct.
┌────────────────────────────────────────┐
│ DAO Botox Mechanism │
└───────────────────┬────────────────────┘
│
Inject 2–4 Units Botulinum Toxin A into Deep DAO
(1 cm lateral & superior to
mandibular border below corner)
│
┌────────────────────────┴────────────────────────┐
│ │
Chemodenervates DAO Allows Unopposed Action
Depressor Muscle of Zygomaticus & Levator
│ Anguli Oris Muscles
▼ ▼
Reduces Downward Pull Restores Neutral/Upward
on Oral Commissure Mouth Corner Position
DAO anatomical parameters
Based on anatomical cadaveric studies (Kim et al., 2023, Toxins, PMC10319486, Novel Anatomical Proposal for Botulinum Neurotoxin Injection Targeting the Depressor Anguli Oris):
- Location: The DAO originates along the oblique line of the mandible and tapers upward toward the modiolus. Its mean inferior width at the mandibular base is approximately 3.6 cm, with a thickness of 0.25 to 0.4 cm.
- Injection Point: Injections are placed 1.0 cm lateral to the oral commissure line and 1.0 cm superior to the lower mandibular border.
- Dosing: 2 to 4 units of Botox/Xeomin (or 6 to 10 units of Dysport) per side.
Avoiding complications: DLI & modiolus risk
Injecting too high (near the modiolus) or too medially (into the Depressor Labii Inferioris / DLI) risks paralyzing the lower lip depressors. This can cause asymmetric lower lip movement, difficulty speaking, or liquid incompetence while drinking. DAO Botox must always be placed deep into the inferior-lateral body of the muscle near the mandibular border.
PDO threads and skin-tightening devices: when filler is the wrong answer
When marionette lines are driven by structural skin laxity and jowl overhang rather than localized volume loss, injecting filler into the crease worsens lower-face heaviness. In these patients, lifting or tightening tissue is required.
| Modality | Primary Mechanism | Clinical Indication |
|---|---|---|
| PDO Cog Threads (Barbed Threads) | Mechanical anchor & vector lifting | Repositioning sagging jowl tissue away from the marionette line |
| Micro-Cored PDO Matrix Threads | Volumizing thread collagen lattice | Collagen meshwork directly under the melomental line |
| Micro-Focused Ultrasound (Ultherapy) | High-intensity MFU thermal points | Deep SMAS-layer thermal contraction & tightening |
| Radiofrequency (Thermage / Sofwave) | Dermal bulk heating | Dermal collagen tightening & surface smoothing |
1. Polydioxanone (PDO) thread lifting
PDO threads offer mechanical repositioning and biostimulatory collagen induction.
- Barbed/Cog Threads: Barbed threads are inserted into the subcutaneous plane above the SMAS layer, anchored near the zygomatic arch or preauricular fascia, and pulled retrogradely to reposition heavy jowl fat away from the marionette crease.
- Volumizing Threads: As demonstrated by Yi et al. (2024, J Cosmet Dermatol, PMC11626340, Marionette Lines Correction with Volumizing Threads), inserting coiled or mesh PDO threads directly beneath the melomental fold triggers localized collagen synthesis, creating a supportive structural matrix that lasts 12 to 24 months. For thread safety profiles, see thread lift evidence and durability.
2. Energy-based skin tightening (Ultherapy / Sofwave)
Micro-focused ultrasound (Ultherapy) delivers targeted acoustic energy to the Superficial Musculoaponeurotic System (SMAS) layer at depths of 4.5 mm, contracting deep fascial planes. Sofwave utilizes parallel ultrasound beams at 1.5 mm to tighten mid-dermal collagen.
3. Surgical lower facelift / neck lift
For severe skin excess, deep jowling, and pronounced melomental folds, non-surgical modalities reach a structural ceiling. A surgical lower rhytidectomy (facelift) mobilizes and redrapes the SMAS layer, providing definitive, long-term correction lasting 10 to 15 years. Compare choices in our guide on jowls treatment without surgery vs facelift.
Marionette lines vs jowls: the decision matrix
| Clinical Presentation | Primary Anatomical Cause | Recommended Treatment Plan |
|---|---|---|
| Isolated hollow line, no jowling | Subcutaneous volume loss / fat atrophy | 1–2 syringes HA filler (Restylane Defyne / Vollure) |
| Downturned mouth corners + line | Hyperactive DAO muscle contraction | 2–4 units DAO Botox per side + 1 syringe HA filler in fold |
| Deep crease + downturned mouth | Volume loss + DAO muscle pull | HA filler in fold + DAO Botox combined |
| Heavy jowl overhang over line | Midface descent + skin laxity | PDO Cog thread lift OR Ultherapy + minimal HA filler |
| Severe skin excess & deep fold | Advanced SMAS laxity & elastosis | Surgical lower facelift / neck lift consultation |
Clinical Safety Protocol: Vascular Risk and Hyaluronidase Management
Injecting dermal fillers into the lower perioral and melomental region requires strict respect for arterial anatomy to prevent vascular occlusion or localized ischemic necrosis.
┌──────────────────────────────────┐
│ Perioral Vascular Map │
└─────────────────┬────────────────┘
│
Facial Artery Ascends over Mandibular Border
│
┌──────────────────────────┴──────────────────────────┐
│ │
Inferior Labial Artery Superior Labial Artery
Branches Medially to Lower Lip Branches to Upper Lip
│ │
└──────────────────────────┬──────────────────────────┘
│
Angular Artery Traverses NLF & Perioral Zone
(Course varies: 42.9% medial, 23.2% lateral,
33.9% crossing the fold plane)
1. Facial and angular artery trajectory
As detailed in Cotofana et al. (2023, J Cosmet Dermatol, PMC10102405, An Illustrated Anatomical Approach to Reducing Vascular Risk During Facial Soft Tissue Filler Administration), the facial artery crosses the inferior border of the mandible just anterior to the masseter muscle and travels tortuously toward the oral commissure. Here, it gives off the inferior and superior labial arteries before continuing as the angular artery along the nasolabial fold.
- Anatomical Variation: Anatomical studies reveal that the angular artery crosses directly through the dermal/subcutaneous plane of the fold in 33.9% of individuals, travels medial to the fold in 42.9%, and runs lateral in 23.2%.
2. Risk-mitigation injection rules
- Blunt micro-cannula preference: Utilizing a 22G or 25G 50mm blunt-tip cannula significantly reduces the risk of arterial puncture compared to sharp needles.
- Aspiration protocol: When using sharp needles for periosteal structural boluses, perform a minimum 5-second aspiration before injecting.
- Low-pressure slow delivery: Inject micro-drops (≤ 0.05 mL per pass) under low pressure to prevent retrograde embolization into the facial arterial system.
3. Emergency vascular occlusion protocol
If blanching, severe pain, reticulated erythema (livedo reticularis), or delayed capillary refill (> 2 seconds) occurs:
- Immediate cessation: Stop injection instantly.
- High-dose hyaluronidase protocol: Immediately flood the ischemic area with 300 to 600 units of hyaluronidase (Hylenex) injected across the anatomical course of the vessel. Repeat hourly if capillary refill remains sluggish.
- Warm compresses & massage: Apply vigorous warm compresses and firm massage to promote vasodilation.
- Adjunctive medical therapy: Prescribe oral aspirin (325 mg/day) and consider topical nitroglycerin paste (2%) to improve micro-vascular perfusion.
[!IMPORTANT] The figures above describe a provider-administered emergency protocol, not patient self-treatment. Published hyaluronidase regimens for suspected vascular occlusion vary widely (from a few hundred to well over a thousand units, sometimes repeated), and management should follow the injector's training and current expert consensus. A patient's role is to recognize the warning signs early — blanching, severe pain disproportionate to the procedure, duskiness, or delayed capillary refill — and alert the provider or seek urgent care immediately.
Step-by-step treatment workflow and patient recovery timeline
A successful marionette line intervention follows a structured clinical pathway from initial consultation to long-term maintenance.
| Timeline Phase | Clinical Actions & Patient Expectations |
|---|---|
| Pre-Treatment (Week −1) | Discontinue NSAIDs/blood thinners 7 days prior; assess smile dynamics and DAO muscular involvement |
| Treatment Day (Day 0) | Prep skin with chlorhexidine; mark DAO points; administer cannula HA filler + intradermal DAO botox |
| Early Recovery (Days 1–3) | Mild swelling & tenderness; avoid intense exercise for 24 hrs; do not massage perioral area |
| Integration (Weeks 1–2) | HA filler binds water; DAO muscle release takes full effect at 10–14 days (upward mouth tilt) |
| Peak Result (Months 1–6) | Full tissue integration; optimal volume lift and smooth perioral skin transition |
| Re-Evaluation (Months 9–12) | Assess HA degradation & DAO muscle re-innervation; schedule maintenance touch-up |
Pre-procedure screening & candidate selection
During initial assessment, the clinician evaluates three dynamic parameters:
- Static crease depth: Measured using the Merz Scale (Grade 0 = no line to Grade 4 = severe deep crease with tissue overhang).
- Dynamic animation: Patient is asked to frown, grimace, and say "E". Marked downward pull of the mouth corners confirms hyperactive DAO involvement requiring neuromodulation.
- Pre-jowl sulcus deficit: Palpating the mandibular border reveals whether volume loss extends into the pre-jowl sulcus, requiring structural support along the chin boundary.
Post-procedure monitoring & patient selection criteria
To ensure optimal clinical outcomes and patient satisfaction, clinicians follow strict screening protocols prior to administering lower-face injectables or thread lifts.
1. Patient selection & exclusion criteria
- Ideal candidates: Patients presenting with mild-to-moderate melomental depression, localized volume loss in the pre-jowl sulcus, or active DAO hypertonicity who seek non-surgical enhancement and understand procedure longevity boundaries.
- Non-candidates (when to defer): Patients with severe, heavy lower-face skin laxity (who require surgical rhytidectomy), active perioral cutaneous infections (herpes simplex, localized folliculitis), severe bleeding diatheses, or unrealistic expectations regarding non-surgical lifting capabilities.
2. Follow-up & touch-up schedule
- 2-Week Follow-Up (Day 14): Patients return for clinical evaluation after local swelling has completely resolved and DAO neuromodulation has achieved peak chemodenervation. Dynamic smile symmetry is assessed. If residual minor depression persists along the melomental crease, a micro-touch-up of 0.2 to 0.4 mL HA filler can be administered.
- 6-Month Maintenance Check: Assess HA filler longevity and DAO muscle recovery. Patients who receive concurrent DAO Botox typically elect a repeat neuromodulator session at 3 to 4 months to maintain elevated oral commissure positioning.
Cost, longevity, and a realistic combined treatment plan
| Option | Average Cost | Duration / Longevity | Ideal Candidate |
|---|---|---|---|
| HA Dermal Filler (1–2 syringes) | $650 – $1,400 total | 12 months | Mild-to-moderate volume loss |
| Radiesse / Sculptra (1–2 vials) | $800 – $1,800 total | 12 to 24 months | Deep structural deflation |
| DAO Botox (4–8 units total) | $100 – $250 total | 3 to 4 months | Downturned mouth corners |
| PDO Thread Lift (Lower Face) | $1,500 – $3,000 | 12 to 24 months | Mild-to-moderate jowl laxity |
| Ultherapy / Sofwave (Lower Face) | $1,800 – $3,500 | 12 to 18 months | Non-surgical skin tightening |
| Surgical Lower Facelift | $9,000 – $18,000+ | 10 to 15 years | Severe skin excess & deep jowls |
Frequently asked questions
How many syringes of filler do marionette lines usually need?
Most patients require 1 to 2 syringes (1.0 mL to 2.0 mL total) of hyaluronic acid filler split between both sides. Mild hollows may be corrected with 1.0 mL, while deeper creases with co-existing pre-jowl volume loss often require 1.5 to 2.0 mL.
How long do marionette-line fillers and threads last?
Hyaluronic acid fillers in the marionette area (such as Restylane Defyne or Juvéderm Vollure) typically last approximately 12 months. Poly-L-lactic acid (Sculptra) and Radiesse last 12 to 24 months. PDO thread lifts provide visible mechanical lifting for 12 to 18 months as the polydioxanone material resorbs and leaves behind new collagen.
Can Botox alone fix marionette lines?
No. Botox injected into the DAO muscle relaxes the downward muscular pull on the mouth corners, but it cannot fill a structural skin crease or restore lost dermal volume. For best results, DAO Botox is combined with HA filler directly in the melomental fold.
Sources
- Cleveland Clinic. Marionette Lines (Melomental Folds): Causes and Treatments. Cleveland Clinic Health Library
- American Society of Plastic Surgeons. 2024 Plastic Surgery Statistics Report (HA fillers 5,331,426, +1%; neuromodulators 9,883,711, +4%). ASPS National Statistics PDF
- Yi KH et al. Marionette lines correction with volumizing threads. J Cosmet Dermatol. 2024. PMC11626340
- Kim HJ et al. Novel anatomical proposal for botulinum neurotoxin injection targeting the depressor anguli oris. Toxins (Basel). 2023;15(7):442. PMC10319486
- Cotofana S et al. An illustrated anatomical approach to reducing vascular risk during facial soft tissue filler administration. J Cosmet Dermatol. 2023;22(4):1180-1188. PMC10102405




